II-VI downgraded by Barclays with a new price target
$IIVI
Barclays downgraded II-VI from Equal-Weight to Underweight and set a new price target of $56.00 from $65.00 previously
Date | Price Target | Rating | Analyst |
---|---|---|---|
8/12/2022 | $75.00 → $59.00 | Overweight → Equal-Weight | Morgan Stanley |
2/10/2022 | $87.00 → $88.00 | Buy | B. Riley Securities |
2/10/2022 | $68.00 → $75.00 | Neutral | Citigroup |
2/10/2022 | $77.00 → $79.00 | Outperform | Raymond James |
2/8/2022 | $85.00 → $84.00 | Buy | Needham |
1/10/2022 | $71.00 → $80.00 | Neutral | BofA Securities |
1/3/2022 | $77.00 | Mkt Perform → Outperform | Raymond James |
12/15/2021 | $80.00 → $82.00 | Equal-Weight → Overweight | Morgan Stanley |